Accessibility Menu
 
SeaStar Medical logo

SeaStar Medical

(NASDAQ) ICU

Current Price$4.11
Market Cap$16.21M
Since IPO (2021)-100%
5 YearN/A
1 Year-68%
1 Month+51%

SeaStar Medical Financials at a Glance

Market Cap

$16.21M

Revenue (TTM)

$1.23M

Net Income (TTM)

$12.15M

EPS (TTM)

$-8.26

P/E Ratio

-0.49

Dividend

$0.00

Beta (Volatility)

0.35 (Low)

Price

$4.11

Volume

71,862.167

Open

$4.20

Previous Close

$4.06

Daily Range

$4.00 - $4.28

52-Week Range

$2.07 - $13.50

ICU News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SeaStar Medical

Industry

Healthcare Equipment and Supplies

Employees

17

CEO

Eric Schlorff

Headquarters

Denver, CO 80216, US

ICU Financials

Key Financial Metrics (TTM)

Gross Margin

96%

Operating Margin

-10%

Net Income Margin

-10%

Return on Equity

-295%

Return on Capital

-1%

Return on Assets

-86%

Earnings Yield

-2.04%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$16.21M

Shares Outstanding

3.99M

Volume

71.86K

Short Interest

0.00%

Avg. Volume

156.86K

Financials (TTM)

Gross Profit

$1.18M

Operating Income

$12.18M

EBITDA

$12.18M

Operating Cash Flow

$13.60M

Capital Expenditure

$0.00

Free Cash Flow

$13.60M

Cash & ST Invst.

$11.98M

Total Debt

$525.00K

SeaStar Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$420.00K

+526.9%

Gross Profit

$408.00K

+509.0%

Gross Margin

97.14%

N/A

Market Cap

$16.21M

N/A

Market Cap/Employee

$853.39K

N/A

Employees

19

N/A

Net Income

$2.90M

+34.3%

EBITDA

$3.02M

+35.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$11.46M

+820.1%

Accounts Receivable

$237.00K

+111.6%

Inventory

$66.00K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$525.00K

-8.5%

Return on Assets

-85.82%

N/A

Return on Invested Capital

-1.17%

N/A

Free Cash Flow

$4.09M

+12.8%

Operating Cash Flow

$4.09M

+12.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
APLMApollomics, Inc.
$14.85-3.57%
BLRXBioLineRx Ltd.
$2.28-0.87%
CTXRCitius Pharmaceuticals, Inc.
$0.84+1.58%
LNAILunai Bioworks Inc.
$0.41+15.99%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.45+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$48.96+0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$67.86-0.02%
NOKNokia
$9.55+0.01%

Questions About ICU

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.